Pharmacodynamics of doxycycline

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.

G. Cornaglia, A. Lönnroth, M. Struelens

Gut bacterial microbiota and obesity

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years.

Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Migrant health—a cause for concern?

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

E. Lindberg, I. Adlerberth, A.E. Wold

N. Messad, L. Landraud, B. Canivet, G. Lina, J. -L. Richard, A

A.E. Muller, U. Theuretzbacher, J.W. Mouton

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Do clinicians consider the results of the BinaxNOW Streptococcus pneumoniae urinary antigen test when adapting antibiotic regimens for pneumonia patients?

Escherichia coli native valve endocarditis

Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,

Vector control: a cornerstone in the malaria elimination campaign

Inga Odenholt, Elisabeth Löwdin, Otto Cars

Do we need new antibiotics?

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.

Training for the infectious diseases speciality in Norway

Pharmacodynamic properties of HMR 3004, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time.

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

Does it make sense to detect Streptococcus pyogenes during tonsillitis in Europe to prevent acute rheumatic fever? S. Edouard, A. Michel-Lepage, D. Raoult

D. Esel, B. Sümerkan, S. Kocagöz Clinical Microbiology and Infection

Bacterial resistance—the clinical challenge

Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria Inga Odenholt, Elisabeth Löwdin,

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae J.M. Sierra,

T.M. File Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

P.M. Hawkey Clinical Microbiology and Infection

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Clinical infection services—the Leiden experience

C. Gagliotti, L. Nobilio, M.L. Moro

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Statin use and clinical outcomes among pneumonia patients

P. Kaltsas, S. Want, J. Cohen Clinical Microbiology and Infection

Clinical Microbiology and Infection

I. Bitar, A. Piazza Clinical Microbiology and Infection

Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting A. Kronenberg, S. Koenig, S. Droz,

The atypical pneumonias: clinical diagnosis and importance

Serum ferritin levels in West Nile encephalitis

Modelling during an emergency: the 2009 H1N1 influenza pandemic

A. Manzur, F. Gudiol Clinical Microbiology and Infection

Carratalà J. Clinical Microbiology and Infection

O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

The first glycopeptide-intermediate Staphylococcus aureus in Oman

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Pharmacodynamics of doxycycline B.A. Cunha, P. Domenico, C.B. Cunha Clinical Microbiology and Infection Volume 6, Issue 5, Pages 270-273 (May 2000) DOI: 10.1046/j.1469-0691.2000.00058-2.x Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Doxycycline kill curves: (a) Staphylococcus aureus; (b) Streptococcus pneumoniae; (c) Pasteurella multocida; (d) Escherichia coli. Clinical Microbiology and Infection 2000 6, 270-273DOI: (10.1046/j.1469-0691.2000.00058-2.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Doxycycline post-antibiotic effects (PAEs) (a) Staphylococcus aureus; (b) Streptococcus pneumoniae; (c) Pasteurella maltophilia; (d) Escherichia coli. Clinical Microbiology and Infection 2000 6, 270-273DOI: (10.1046/j.1469-0691.2000.00058-2.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions